Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Alone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma or for Whom Transplant Is Not Planned As Initial Therapy: Analysis of Minimal Residual Disease in the Cepheus Trial
来那度胺
达拉图穆马
硼替佐米
医学
多发性骨髓瘤
地塞米松
内科学
肿瘤科
移植
沙利度胺
外科
作者
Sonja Zweegman,Thierry Façon,Vânia Hungria,Nizar J. Bahlis,Christopher P. Venner,Marc Braunstein,Luděk Pour,Josep Marti Tutusaus,Supratik Basu,Yaël Cohen,Morio Matsumoto,Kenshi Suzuki,Cyrille Hulin,Sebastian Grosicki,Wojciech Legieć,Meral Beksaç,Ângelo Maiolino,Hiroyuki Takamatsu,Aurore Perrot,Mehmet Turgut,Weiping Liu,Jianping Wang,Katherine Chastain,Jessica Vermeulen,Maria Krevvata,Lorena Lopez-Masi,Jodi Carey,Melissa Rowe,Richard G. Carson,Saad Z. Usmani
出处
期刊：Blood [American Society of Hematology] 日期：2024-11-05卷期号：144 (Supplement 1): 362-362
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
归尘
橘x
无极微光
ckeong89
蓝莓橘子酱
互助
Auston_zhong
干净的琦
luoxiyysgt
pancake
你嵙这个期刊没买
lxaiczn
跳跃的夜柳
只争朝夕
贪玩的秋柔
殷勤的紫槐
DotBlot
GingerF
snubdisphenoid
皖公网安备34019202002308
